Introducing DIAGNOS Inc.

Disrupting the degenerative eye screening industry.

DIAGNOS Inc. (DGNOF) (ADK.V) is pending regulatory approval in Canada, Saudi Arabia, and the U.S. for its (Computer-Assisted Retina Analysis) (“CARA”) software system that uses AI to analyze retinal images for the detection of degenerative eye diseases, such as diabetic retinopathy, hypertensive retinopathy, age-related macular degeneration (AMD), and g…